Neurodevelopmental Outcomes following Intrauterine Growth Restriction and Very Preterm Birth

Chiara Sacchi1, Jonathan O'Muircheartaigh2, Dafnis Batalle2

  • 1Department of Developmental and Social Psychology, University of Padova, Padua, Italy.

Insights

Intrauterine growth restriction (IUGR) in very preterm infants is linked to altered brain development and worse outcomes in toddlerhood. This suggests IUGR may increase neurodevelopmental risks beyond very preterm birth alone.

Area of Science:

  • Neuroscience
  • Developmental Pediatrics
  • Neonatology

Background:

  • Very preterm birth poses significant neurodevelopmental risks.
  • Intrauterine growth restriction (IUGR) is a common complication of pregnancy.
  • The combined impact of IUGR and very preterm birth on neurodevelopment is not fully understood.

Purpose of the Study:

  • To investigate if IUGR exacerbates neurodevelopmental risks in very preterm infants.
  • To examine alterations in brain growth and toddlerhood outcomes in very preterm infants with and without IUGR.

Main Methods:

  • 314 very preterm infants from the Evaluation of Preterm Imaging Study (e-Prime) were assessed.
  • IUGR was identified based on postnatal records and prenatal growth parameters.
  • Brain structure was evaluated using MRI at term-equivalent age.
  • Neurodevelopmental outcomes were assessed at 22 months using standardized tests.

Main Results:

  • Infants with IUGR showed distinct gray matter volume alterations, particularly in limbic and frontoinsular regions.
  • Toddlers born very preterm with IUGR had significantly lower cognitive and motor scores.
  • Increased likelihood of positive autism screening was observed in toddlers with IUGR.

Conclusions:

  • IUGR may confer additional neurodevelopmental risk beyond very preterm birth.
  • Altered brain growth patterns are associated with IUGR in this population.
  • Poorer toddlerhood cognitive, motor, and autism-related outcomes are linked to IUGR in very preterm infants.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.2K
Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the...
43.5K
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
21.2K